NCT02182596View on ClinicalTrials.gov

DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

January 31, 2011

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

Mylotarg

Dose level study

Trial Locations (15)

14033

CH, Caen

59037

CHU, Lille

59100

CH, Roubaix

75012

St Antoine Hospital, Paris

76038

CHU, Rouen

77104

CH, Meaux

87042

CH, Limoges

92141

Hopital Percy, Clamart

94010

CHU, Créteil

94805

IGR, Villejuif

Unknown

Hopital Avicenne, Bobigny

Hopital Edouard Herriot, Lyon

Hopital Saint-Louis, Paris

CNLCC, Saint-Cloud

CH, Versailles

All Listed Sponsors

lead

Acute Leukemia French Association

OTHER

NCT02182596 - DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML | Biotech Hunter | Biotech Hunter